DR. REDDY'S LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,059 INR | +2.75% |
|
+4.69% | +4.50% |
| Jun. 07 | Asian Equities Traded in the US as American Depositary Receipts Nudge Lower Friday; Set to End Week With Slight Gain | MT |
| Jun. 04 | Dr. Reddy's Arm Opens Biologics Facility in Hyderabad, India | MT |
ETFs positioned on Dr. Reddy's Laboratories Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.02% | 6 M€ | +6.07% | - | |
| 0.33% | 1 M€ | +3.49% | - | |
| 0.33% | 3 M€ | -.--% | - | |
| 0.20% | 11 M€ | +4.31% | ||
| 0.12% | 2,838 M€ | +8.49% | - | |
| 0.12% | 451 M€ | +6.10% | - | |
| 0.12% | 152 M€ | +5.71% | - | |
| 0.10% | 4 M€ | -4.41% | - | |
| 0.05% | 114 M€ | +4.36% | - | |
| 0.05% | 0 M€ | 0.00% | - | |
| 0.04% | 35 M€ | +5.55% | - | |
| 0.03% | 7 M€ | +5.53% | - | |
| 0.03% | 13 M€ | +20.38% | - | |
| 0.02% | 15 M€ | +15.02% | ||
| 0.01% | 36 M€ | +9.83% | - | |
| 0.01% | 47 M€ | 0.00% | - | |
| 0.01% | 414 M€ | +10.01% | - | |
| 0.01% | 40 M€ | +6.57% | - | |
| 0.01% | 324 M€ | +6.59% | - | |
| 0.01% | 32 M€ | +4.30% | - | |
| 0.01% | 104 M€ | +4.15% | - | |
| 0.01% | 17 M€ | +3.59% | - | |
| 0.01% | 55 M€ | +1.07% | - | |
| 0.01% | 15 M€ | -3.61% |
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Sector
Pharmaceuticals
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
35
Last Close Price
6,059
INR
Average target price
6,114
INR
Spread / Average Target
+0.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.50% | 12.08B | |
| +45.82% | 765B | |
| -6.16% | 354B | |
| +19.86% | 331B | |
| +9.32% | 299B | |
| +18.45% | 248B | |
| -0.78% | 219B | |
| +11.88% | 216B | |
| +5.90% | 164B | |
| -0.73% | 162B |
- Stock Market
- Equities
- DRREDDY Stock
- Funds and ETFs Dr. Reddy's Laboratories Limited
